Dayton, OH, United States of America

Christ Tamborski


Average Co-Inventor Count = 1.8

ph-index = 10

Forward Citations = 254(Granted Patents)


Company Filing History:


Years Active: 1977-1987

Loading Chart...
19 patents (USPTO):Explore Patents

Title: Inventor Christ Tamborski: Innovations in X-ray Contrast Agents and Phosphines

Introduction

Christ Tamborski is an esteemed inventor based in Dayton, OH, with a remarkable record of 19 patents to his name. His innovative contributions primarily focus on advancements in medical imaging and antioxidation additives, reflecting his dedication to improving technology in these fields.

Latest Patents

Among his latest inventions, Tamborski has developed a method for utilizing perfluorobromoalkyl ethers as X-ray contrast agents. This method involves using a compound defined by the formula C.sub.m F.sub.2m+1 OC.sub.n F.sub.2n Br, where both m and n are integers ranging from 2 to 6. The ether can be applied either in its neat form or as part of an aqueous dispersion such as an emulsion. Furthermore, he has created perfluoroalkylether substituted phenyl phosphines, which are fluorinated phosphines with a general formula beneficial as antioxidation additives for perfluorinated fluids.

Career Highlights

Tamborski has had an impactful career, contributing his expertise to notable organizations such as the United States of America, represented by the Secretary of the Air, and Adamantech, Inc. His work in these institutions has paved the way for significant advances in the fields of chemistry and medical technology.

Collaborations

Throughout his career, Tamborski has collaborated with distinguished colleagues, notably John B. Christian and Carl E. Snyder, Jr. Their combined expertise has not only fostered innovation but also strengthened research initiatives within their respective fields.

Conclusion

Christ Tamborski exemplifies the spirit of innovation through his substantial contributions to technology in medical imaging and antioxidation. With 19 patents, his work continues to influence the industry, ensuring better solutions for both healthcare providers and researchers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…